UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2013, Volume 57, Issue 5, pp. 2231 - 2242
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Nucleoproteins - chemistry | Influenza A Virus, H3N2 Subtype - drug effects | Influenza A Virus, H3N2 Subtype - metabolism | Naproxen - pharmacology | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Viral Proteins - metabolism | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | RNA, Viral - antagonists & inhibitors | Antiviral Agents - chemistry | Madin Darby Canine Kidney Cells | RNA, Viral - metabolism | Binding Sites | Influenza A Virus, H1N1 Subtype - metabolism | Orthomyxoviridae Infections - drug therapy | Antiviral Agents - pharmacology | Viral Proteins - chemistry | Viral Proteins - antagonists & inhibitors | Drug Repositioning | Influenza A Virus, H1N1 Subtype - drug effects | Drug Discovery | Molecular Dynamics Simulation | Nucleoproteins - antagonists & inhibitors | Naproxen - chemistry | Point Mutation | Animals | Influenza A Virus, H3N2 Subtype - chemistry | RNA, Viral - chemistry | Nucleoproteins - metabolism | Dogs | Protein Binding | Influenza A Virus, H1N1 Subtype - chemistry | Mice | Molecular Docking Simulation | Orthomyxoviridae Infections - virology | Index Medicus | Anti-Inflammatory Agents, Non-Steroidal | Influenza A Virus, H3N2 Subtype | Nucleoproteins | Biochemistry, Molecular Biology | Viral Proteins | Antiviral Agents | Life Sciences | Naproxen | RNA, Viral | Influenza A Virus, H1N1 Subtype | Biomolecules | Orthomyxoviridae Infections
Journal Article
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 11/2016, Volume 60, Issue 11, pp. 6679 - 6691
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | DNA-Directed RNA Polymerases - antagonists & inhibitors | Influenza A Virus, H3N2 Subtype - drug effects | Humans | Influenza A Virus, H3N2 Subtype - metabolism | Reassortant Viruses - genetics | Reassortant Viruses - drug effects | Structure-Activity Relationship | Influenza A Virus, H3N2 Subtype - genetics | IMP Dehydrogenase - genetics | Influenza A Virus, H1N1 Subtype - growth & development | Viral Proteins - metabolism | Influenza A Virus, H3N2 Subtype - growth & development | RNA, Viral - antagonists & inhibitors | Antiviral Agents - chemistry | Madin Darby Canine Kidney Cells | Influenza A Virus, H1N1 Subtype - genetics | Influenza A Virus, H1N1 Subtype - metabolism | Amides - pharmacology | A549 Cells | Virus Replication - drug effects | Antiviral Agents - pharmacology | Reassortant Viruses - metabolism | RNA, Viral - biosynthesis | Viral Proteins - genetics | Viral Proteins - antagonists & inhibitors | DNA-Directed RNA Polymerases - genetics | Ribavirin - chemistry | Influenza A Virus, H1N1 Subtype - drug effects | Chick Embryo | Reassortant Viruses - growth & development | IMP Dehydrogenase - metabolism | Pyrazines - chemistry | Animals | Mutation - drug effects | Sequence Analysis, RNA | IMP Dehydrogenase - antagonists & inhibitors | Gene Expression Regulation, Viral | Dogs | Amides - chemistry | DNA-Directed RNA Polymerases - metabolism | Pyrazines - pharmacology | Ribavirin - pharmacology | Index Medicus
Journal Article
Journal of virology, ISSN 0022-538X, 2016, Volume 90, Issue 21, pp. 9693 - 9711
Life Sciences & Biomedicine | Science & Technology | Virology | Virulence - drug effects | Influenza A Virus, H3N2 Subtype - drug effects | Humans | Immunity, Innate - genetics | Cercopithecus aethiops | Influenza A Virus, H3N2 Subtype - genetics | Leukocytes, Mononuclear - virology | HEK293 Cells | Immune Evasion - genetics | Influenza, Human - virology | Influenza A Virus, H1N1 Subtype - genetics | Vero Cells | A549 Cells | Cell Line | Antiviral Agents - pharmacology | Interferons - pharmacology | Influenza A Virus, H3N2 Subtype - pathogenicity | Viral Nonstructural Proteins - genetics | Influenza A Virus, H1N1 Subtype - pathogenicity | Influenza A Virus, H1N1 Subtype - drug effects | Mutation - genetics | Animals | Immune Evasion - drug effects | RNA, Double-Stranded - genetics | Cell Line, Tumor | Cleavage And Polyadenylation Specificity Factor - genetics | Index Medicus
Journal Article
The Journal of infectious diseases, ISSN 0022-1899, 7/2007, Volume 196, Issue 2, pp. 249 - 257
Influenza A virus | Antivirals | Phylogenetics | Viruses | Amino acids | Orthomyxoviridae | Evolution | Infections | Preventive medicine | Drug resistance | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Antiviral agents | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Antiviral Agents - pharmacology | Global Health | Influenza A Virus, H3N2 Subtype - drug effects | Humans | Drug Resistance, Viral | Influenza A Virus, H3N2 Subtype - genetics | Phylogeny | Influenza A Virus, H1N1 Subtype - drug effects | Hemagglutinin Glycoproteins, Influenza Virus - genetics | Microbial Sensitivity Tests | Amantadine - pharmacology | Influenza A Virus, H1N1 Subtype - genetics | Sentinel Surveillance | Rimantadine - pharmacology | Influenza viruses | Prevention | Amantadine | Analysis | Influenza | Patient outcomes | Development and progression | Research | Index Medicus | Abridged Index Medicus
Journal Article
The Journal of infectious diseases, ISSN 0022-1899, 01/2020, Volume 221, Issue 1, pp. 63 - 70
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Thiepins - therapeutic use | Triazines - therapeutic use | Thiepins - pharmacology | Influenza A Virus, H3N2 Subtype - genetics | Viral Proteins - metabolism | Lung - virology | Madin Darby Canine Kidney Cells | Inhibitory Concentration 50 | Female | Influenza A Virus, H1N1 Subtype - genetics | Orthomyxoviridae Infections - drug therapy | Oxazines - pharmacology | Pyridines - therapeutic use | Virus Replication - drug effects | Antiviral Agents - pharmacology | Triazines - pharmacology | Influenza A Virus, H3N2 Subtype - enzymology | RNA-Dependent RNA Polymerase - genetics | Antiviral Agents - therapeutic use | Influenza A Virus, H3N2 Subtype - pathogenicity | Mice, Inbred C57BL | Pyridones | RNA-Dependent RNA Polymerase - metabolism | Viral Proteins - genetics | Influenza A Virus, H1N1 Subtype - pathogenicity | Morpholines | Drug Resistance, Viral - genetics | Phenotype | Animals | Influenza A Virus, H1N1 Subtype - enzymology | Oxazines - therapeutic use | Dogs | Dibenzothiepins | Mice | Pyridines - pharmacology | Mutation | Viral Load - drug effects | Orthomyxoviridae Infections - virology | Amino Acid Substitution | Polymerase chain reaction | Oseltamivir | Cell culture | Influenza | Virulence | Viruses | Influenza A | Experiments | Fitness | Mutants | Index Medicus | Abridged Index Medicus | influenza | Major and Brief Reports | A(H3N2) | I38T | A(H1N1)pdm09 | baloxavir | resistance
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 2/2009, Volume 48, Issue 4, pp. 389 - 396
Cercopithecine herpesvirus 1 | Influenza A virus | Reverse transcriptase polymerase chain reaction | Articles and Commentaries | Antivirals | Viruses | Orthomyxoviridae | Children | Drug resistance | Inhibitory concentration 50 | H3N2 subtype influenza A virus | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Influenza A Virus, H3N2 Subtype - drug effects | Oseltamivir - therapeutic use | Humans | Influenza A virus - genetics | Drug Resistance, Viral | Child, Preschool | Neuraminidase - genetics | Infant | Male | Influenza A Virus, H3N2 Subtype - genetics | Viral Load | Microbial Sensitivity Tests | Influenza B virus - genetics | Influenza A Virus, H1N1 Subtype - isolation & purification | Influenza A Virus, H3N2 Subtype - isolation & purification | Female | Influenza, Human - virology | Influenza B virus - drug effects | Influenza, Human - drug therapy | Child | Influenza A Virus, H1N1 Subtype - genetics | Antiviral Agents - therapeutic use | Influenza B virus - isolation & purification | Viral Proteins - genetics | Influenza A virus - isolation & purification | Influenza A Virus, H1N1 Subtype - drug effects | Sequence Analysis, DNA | Influenza A virus - drug effects | Influenza | Patient outcomes | Reports | Drug therapy | Diseases | Virology | Children & youth | Index Medicus
Journal Article
Experimental biology and medicine (Maywood, N.J.), ISSN 1535-3702, 12/2015, Volume 240, Issue 12, pp. 1630 - 1639
viral replication | inhibition | miRNA | miR-3145 | silencing | influenza A virus | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Virus Replication - drug effects | Antiviral Agents - pharmacology | Gene Silencing - drug effects | Influenza A Virus, H3N2 Subtype - drug effects | Influenza A Virus, H5N1 Subtype - physiology | Virus Replication - genetics | Influenza A Virus, H1N1 Subtype - physiology | Influenzavirus A - physiology | Viral Proteins - genetics | Viral Proteins - antagonists & inhibitors | Influenza A Virus, H5N1 Subtype - drug effects | Influenza A Virus, H5N1 Subtype - genetics | Influenza A Virus, H3N2 Subtype - genetics | Influenza A Virus, H1N1 Subtype - drug effects | MicroRNAs - pharmacology | Influenzavirus A - drug effects | Genes, Viral - drug effects | Influenza A Virus, H3N2 Subtype - physiology | Influenza A Virus, H1N1 Subtype - genetics | Real-Time Polymerase Chain Reaction | Influenzavirus A - genetics | Index Medicus | Original Research
Journal Article
Journal of Virology, ISSN 0022-538X, 02/2014, Volume 88, Issue 3, pp. 1447 - 1460
Life Sciences & Biomedicine | Science & Technology | Virology | Small Molecule Libraries - pharmacology | Influenza A Virus, H3N2 Subtype - drug effects | Influenza A Virus, H5N1 Subtype - physiology | Humans | Influenza A virus - genetics | Influenza A Virus, H1N1 Subtype - physiology | Influenza A Virus, H5N1 Subtype - genetics | Influenza A Virus, H3N2 Subtype - genetics | Virus Internalization - drug effects | Antiviral Agents - chemistry | Influenza, Human - virology | Influenza A Virus, H1N1 Subtype - genetics | Cell Line | Influenza A virus - physiology | Antiviral Agents - pharmacology | Hemagglutinins, Viral - metabolism | Hemagglutinins, Viral - genetics | Influenza A Virus, H5N1 Subtype - drug effects | Poultry Diseases - virology | Influenza A Virus, H1N1 Subtype - drug effects | Small Molecule Libraries - chemistry | Animals | Chickens | Influenza in Birds - virology | Influenza A Virus, H3N2 Subtype - physiology | Influenza A virus - drug effects | Index Medicus | Vaccines and Antiviral Agents
Journal Article
Scientific reports, ISSN 2045-2322, 04/2017, Volume 7, Issue 1, pp. 45723 - 45723
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Lung - pathology | Influenza A Virus, H3N2 Subtype - drug effects | Humans | Influenza A Virus, H1N1 Subtype - drug effects | Antiviral Agents - administration & dosage | Lung - virology | Animals | Lung - drug effects | Dogs | Madin Darby Canine Kidney Cells | Female | Neuraminidase - antagonists & inhibitors | Mice, Inbred BALB C | Chlorogenic Acid - administration & dosage | Influenza, Human - prevention & control | Oseltamivir | Animal models | Intravenous administration | Influenza | Exo-a-sialidase | Antiviral activity | NP protein | Respiratory tract diseases | Chlorogenic acid | Immunofluorescence | Parainfluenza | Hepatitis B | Index Medicus
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 09/2008, Volume 52, Issue 9, pp. 3284 - 3292